Fatty acid synthase, Her2/neu, and E2F1 as prognostic markers of progression in non-muscle invasive bladder cancer

Faculty Medicine Year: 2019
Type of Publication: ZU Hosted Pages:
Authors:
Ahmed Alsayed Othman Sliem Elazony
Journal: المجلة الطبية لجامعة القاهرة- عدد 87 , رقم 3 , يونيو –من (1639-1647)، 2019 م Annals of Diagnostic Pathology 39 (2019) 42–52 Volume:
Keywords : Fatty acid synthase, Her2/neu, , E2F1 , prognostic    
Abstract:
Non-muscle-invasive bladder cancer (NMIBC) is a heterogeneous disease which has an unpredictable risk of progression to muscle-invasive bladder cancer (MIBC). The selection of patients who may benefit from early radical intervention is a
   
     
 
       

Author Related Publications

  • Ahmed Alsayed Othman Sliem Elazony, "The Relation between the Severity of Pain and Common Symptoms in Patients with Metastatic Cancer", Research in Oncology 2018; Vol. 14, No. 1: 43-46., 2017 More
  • Ahmed Alsayed Othman Sliem Elazony, "Prognostic and therapeutic implications of lysyl oxidase and cyclooxygenase 2 expressions in epithelial ovarian carcinoma", International Medicine 2019; 1(5):, 2019 More
  • Ahmed Alsayed Othman Sliem Elazony, "Effect of Continuous Relatively High Dose Tamoxifen on Survival of Patients with Recurrent Glioblastoma Multifome", Journal of Cancer Prevention & Current Research, 2016 More
  • Ahmed Alsayed Othman Sliem Elazony, "Assessment of radiological pulmonary shadows in patients with extra pulmonary neoplasm", Egyptian Journal of Chest Diseases and Tuberculosis 66 (2017) 681–686, 2017 More
  • Ahmed Alsayed Othman Sliem Elazony, "Fatty acid synthase, Her2/neu, and E2F1 as prognostic markers of progression in non-muscle invasive bladder cancer", Annals of Diagnostic Pathology 39 (2019) 42–52, 2019 More

Department Related Publications

  • Rehab Hemida Elsayed Muhammad, "Abbreviated Concurrent Chemo-Radiotherapy in NodeNegative Muscle-Invasive Bladder Cancer العلاج الكيميائي الإشعاعي المختصر المتزامن في سرطان المثانة الغزوي للعضلات العقدية السلبية", SECI Oncology, 2021 More
  • Doaa Abdelrahman Elsayed Mandour, "Concordance Between ER, PR, HER2 neu Receptors Before and After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. تقديم العلاج الكيميائي في مرضى سرطان الثدي قبل اجراء العملية الجراحية المتزامن مع التغيرات في مستقبلات هرمون الاستروجين (اي آر) ومستقبلات هرمون البروجسترون (بي آر) وهير 2 نيو", Forum of Clinical Oncology, 2020 More
  • Doaa Abdelrahman Elsayed Mandour, "The value of fertility-sparing surgery for young females with epithelial ovarian cancer: a comparative study قيمة جراحة الحفاظ على الخصوبة للشابات المصابات بسرطان المبيض: دراسة مقارنة", CURR GYNECOL ONCOL, 2021 More
  • Doaa Abdelrahman Elsayed Mandour, "Abbreviated Concurrent Chemo-Radiotherapy in NodeNegative Muscle-Invasive Bladder Cancer العلاج الكيميائي الإشعاعي المختصر المتزامن في سرطان المثانة الغزوي للعضلات العقدية السلبية", SECI Oncology, 2021 More
  • Lubna Abdul -Aziz Abdul- Aziz Muhamed, "Prognostic significance of lymphocyte-to-monocyte ratio in patients with classical Hodgkin lymphoma before and after receiving first-line chemotherapy", termedia publishing house Ltd, 2022 More
Tweet